1600201

Regorafenib

United States Pharmacopeia (USP) Reference Standard

• Synonyme(s) : Regorafenib monohydrate, 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate
• Formule empirique (notation de Hill): C₂₁H₁₅ClF₄N₄O₃ · H₂O
• Numéro CAS: 1019206-88-2
• Poids moléculaire : 500.83
• Code UNSPSC : 41116107
• Nomenclature NACRES : NA.24

Propriétés

• Famille d'API: regorafenib
• Fabricant/nom de marque: USP
• Application(s): pharmaceutical (small molecule)
• Format: neat
• Température de stockage: 15-25°C
• InChI: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2
• Clé InChI: ZOPOQLDXFHBOIH-UHFFFAOYSA-N

Description

Description générale

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Application

Regorafenib USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Autres remarques

Sales restrictions may apply.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS09
• Mention d'avertissement: Warning
• Mentions de danger: H361fd,H373,H410
• Conseils de prudence: P202 - P260 - P273 - P280 - P308 + P313 - P391
• Classification des risques: Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2
• Organes cibles: Liver
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable